NCDActive
Stereotaxic Depth Electrode Implantation
NCD216
Effective: January 1, 1966
Updated: December 31, 2025
Policy Summary
Stereotaxic depth electrode implantation is covered for patients with focal epilepsy who have failed anticonvulsant therapy and require invasive EEG monitoring to localize resectable seizure foci, especially when scalp EEG is non-diagnostic. The policy implies use as a pre-surgical localization tool; it does not specify documentation, frequency limits, or detailed exclusions, so payer-specific prior authorization and documentation requirements should be confirmed.
Coverage Criteria Preview
Key requirements from the full policy
"Stereotaxic depth electrode implantation is covered for patients with focal epilepsy who are unresponsive to anticonvulsant medications and are being evaluated prior to surgical treatment to locali..."
Sign up to see full coverage criteria, indications, and limitations.